Home Innovation Science and Technology Study Calls for Region-Specifi...

Study Calls for Region-Specific Guidelines to Combat H. pylori

Science and Technology

Business Honor
19 March, 2025

International study highlights the need for tailored guidelines to fight H. pylori and prevent gastric cancer.

Helicobacter pylori (H. pylori) bacteria have long been accepted as the main etiology of gastric cancer, most prevalent in the Asia-Pacific area. It has been associated with approximately 90% of gastric cancer occurrences, but doctors are recommending eradication of the bacteria at the early stages, and this might help lower gastric cancer cases by 30-40%. Regardless, the emergent problem of resistance to antimicrobial drugs used for eradication treatment is a main concern.

Aside from primary prevention via H. pylori treatment, secondary prevention via routine endoscopic screening is also a crucial factor in early gastric cancer detection. Yet it is uncertain to what degree Asia-Pacific practitioners recognize and apply these interventions.

An international study team headed by Dr. Koji Otani and Professor Yasuhiro Fujiwara of the Osaka Metropolitan University Graduate School of Medicine performed an online survey to evaluate treatment policies for H. pylori in the Asia-Pacific region. The survey collected data from clinicians on diagnosis approaches, dosages of antibacterial drugs, durations of treatment, and secondary prevention roles. The results indicated an increasing agreement on the significance of primary and secondary prevention of gastric cancer associated with H. pylori infections.

Yet, the research also pointed out extreme differences in levels of antimicrobial resistance, incidence rates of gastric cancer, and availability of medical facilities between regions, which pose a challenge to adopting a single strategy for prevention. Differences in healthcare policies at the regional level also contribute to these discrepancies. In the future, the study underscores the importance of formulating country-specific guidelines for treatment taking into account the peculiarities of antimicrobial resistance and gastric cancer in each nation.

Dr. Koji Otani underscored the necessity of adapting prevention measures to each countries healthcare situations so as to best fight H. pylori infection and minimize gastric cancer risk within the Asia-Pacific region.